LITERATURE REVIEW: PENGARUH SOCIAL SUPPORT TERHADAP KEPATUHAN MINUM OBAT ANTI TUBERKULOSIS PADA PASIEN TUBERKULOSIS (TBC) PARU
DOI:
https://doi.org/10.32584/jpi.v7i2.1529Abstract
Abstrak
Penanggulangan TBC secara nasional menggunakan Obat Anti Tuberkulosis (OAT) yang
diberikan kepada penderita dalam jangka 6-8 bulan pengobatan. Keberhasilan program
pengobatan TBC sangat dipengaruhi oleh kepatuhan minum obat yang lengkap sampai
selesai. Tingginya angka kejadian TBC salah satunya dipengaruhi oleh ketidakpatuhan
dalam pengobatan. Tujuan penelitian ini adalah untuk mengetahui pengaruh social
support terhadap kepatuhan minum obat anti tuberkulosis. Metode literature review
(LR) dimana data yang digunakan adalah database pencarian menggunakan MEDLINE
(PubMed), Google Scholar, Science Direct, dan Wiley. Laporan yang diterbitkan dari 2012-
2021 yang berfokus pada social support terhadap kepatuhan minum obat anti
tuberkulosis. Hasil penelitian ini berdasarkan analisis jurnal, terdapat implikasi
keperawatan yang dibandingkan dari 8 jurnal, ditemukan bahwa metode peningkatan
kepatuhan minum obat anti tuberkulsois dengan teknik social support berpengaruh
dalam meningkatkan kepatuhan minum obat anti tuberkulosis. Kesimpulan yaitu
metode social support terbukti berpengaruh dalam upaya peningkatan kepatuhan
minum obat tuberkulosis karena dalam minum obat tuberkulosis dibutuhkan waktu 6-
7 bulan secara continue. Peneliti menyarankan agar petugas kesehatan, keluarga dan
penderita bekerja sama dalam mewujudkan kepatuhan minum obat anti tuberkuloasis
dengan menggunakan metode Social Support.
Kata Kunci: Kepatuhan Minum Obat, Social Support, Tuberkulosis.
Abstract
National TB control uses Anti Tuberculosis Drugs (OAT) given to patients within 6-8
months of treatment. The success of the TB treatment program is strongly influenced by
complete medication adherence to completion. The high incidence of TB is influenced by
non-adherence in treatment. The purpose of this study was to determine the effect of social
support on adherence to taking anti-tuberculosis drugs. Literature review (LR) method
where the data used is a search database using MEDLINE (PubMed), Google Scholar,
Science Direct, and Wiley. A report published from 2012-2021 that focuses on social
support for adherence to taking anti-tuberculosis drugs. The results based on the analysis
of journals, there are nursing implications compared from 8 journals, it was found that the
method of increasing adherence to taking anti-tuberculosis drugs with social support
techniques had an effect on increasing adherence to taking anti-tuberculosis drugs. The
conclution of The social support method has been proven to have an effect in increasing
adherence to tuberculosis medication because it takes 6-7 months to take tuberculosis
medication continuously. Researchers suggest that health workers, families and patients
work together in realizing adherence to taking anti-tuberculosis drugs using the Social
Support method.
Keywords: Adherence or Social Support or Tuberculosis
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
This work is licensed under a Creative Commons Attribution 4.0 International License.
